ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $46,513,000 | +9.7% | 896,724 | 0.0% | 0.99% | -12.2% |
| Q2 2022 | $42,389,000 | -38.2% | 896,724 | -7.0% | 1.13% | -24.6% |
| Q1 2022 | $68,633,000 | +593.8% | 964,212 | +285.7% | 1.50% | +28.1% |
| Q3 2014 | $9,893,000 | -85.1% | 250,000 | -83.8% | 1.17% | -82.6% |
| Q2 2014 | $66,310,000 | +7.6% | 1,539,586 | -0.1% | 6.70% | +51.7% |
| Q1 2014 | $61,628,000 | +697.9% | 1,541,078 | +253.3% | 4.42% | +331.6% |
| Q2 2013 | $7,724,000 | – | 436,145 | – | 1.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 476,042 | $45,472,000 | 12.29% |
| Stonepine Capital Management, LLC | 60,840 | $5,811,000 | 3.34% |
| ACUTA CAPITAL PARTNERS, LLC | 61,000 | $5,827,000 | 2.77% |
| Virtus ETF Advisers LLC | 10,634 | $1,016,000 | 2.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 61,000 | $5,827,000 | 2.15% |
| ARMISTICE CAPITAL, LLC | 372,000 | $35,533,000 | 1.94% |
| Matarin Capital Management, LLC | 209,403 | $20,002,000 | 1.46% |
| Monashee Investment Management LLC | 50,000 | $4,776,000 | 1.10% |
| Granahan Investment Management | 151,322 | $14,454,000 | 0.78% |
| ALGERT GLOBAL LLC | 13,186 | $1,260,000 | 0.72% |